Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
19,309,579
-
Shares change
-
+2,879,249
-
Total reported value, excl. options
-
$1,350,723,574
-
Value change
-
+$209,084,528
-
Put/Call ratio
-
117%
-
Number of buys
-
89
-
Number of sells
-
-43
-
Price
-
$69.95
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2021
177 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q4 2021.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,309,579 shares
of 29,067,614 outstanding shares and own 66.43% of the company stock.
Largest 10 shareholders include FMR LLC (1,978,284 shares), Point72 Asset Management, L.P. (1,856,156 shares), Redmile Group, LLC (1,820,898 shares), BlackRock Inc. (1,605,496 shares), LORD, ABBETT & CO. LLC (1,173,863 shares), VANGUARD GROUP INC (1,023,610 shares), BAKER BROS. ADVISORS LP (807,735 shares), FRAZIER MANAGEMENT LLC (771,250 shares), CREDIT SUISSE AG/ (753,680 shares), and STATE STREET CORP (701,801 shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.